West Pharmaceutical Services
Logotype for West Pharmaceutical Services Inc

West Pharmaceutical Services (WST) investor relations material

West Pharmaceutical Services Jefferies Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for West Pharmaceutical Services Inc
Jefferies Global Healthcare Conference summary18 Nov, 2026

Customer engagement and strategy

  • Prioritizing relationships with pharma and biotech supply-chain leaders to understand demand scenarios, clinical pipelines and manufacturing needs beyond procurement-level order discussions.

  • Planning regular, customer-specific engagement, including reciprocal site visits and agendas on innovation adoption and contamination control.

  • Customer discussions are in early stages; insights on delivery technologies and modalities may guide relevant product extensions over time.

  • Organic growth, product upgrades and productivity remain priorities; inorganic options may be evaluated patiently as customer needs become clearer.

Demand and customer visibility

  • GLP-1s represent ~10% of total revenue; broad market participation, access gains and next-generation products support optimism on the class’s long-term growth.

  • Growth is broad-based, with HVP upgrades also contributing; management described GLP-1s as a continuing growth tailwind.

  • Customers typically provide a view of the coming year during annual planning; order patterns become firmer as delivery approaches.

  • Diverse customers and products, alongside lasting demand trends, support management’s confidence in aggregate growth prospects for the period ahead.

HVP upgrades and capacity

  • HVP upgrades are expected to add 200 bps of growth in 2026; more than 800 projects are completed or underway, with additional projects in the pipeline.

  • Europe has upgraded a little over 1 billion of an estimated 6 billion components, or about 20%; projects are expanding in the U.S., where adoption remains early.

  • Management views the upgrade cycle as a durable, multi-year tailwind, supported by contamination-control requirements and regulatory expectations across regions.

  • Upgrades can raise price and margin percentage at similar volumes; NovaPure products are positioned to support further movement to higher standards.

  • Molding capacity is expected to be sufficient through at least decade-end; added finishing capacity is planned to come online in late 2028 as volumes grow.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next West Pharmaceutical Services earnings date

Logotype for West Pharmaceutical Services Inc
Q4 202611 Feb, 2027
West Pharmaceutical Services
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next West Pharmaceutical Services earnings date

Logotype for West Pharmaceutical Services Inc
Q4 202611 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products worldwide. It offers components and systems that are used by pharmaceutical and biotech companies to deliver drugs safely to patients and enable lifestyle-enhancing drugs to be injected safely, accurately, comfortably, and conveniently. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.